Brief: Cormedix Completes Acquisition Of Melinta Therapeutics, Raises Financial Guidance And Announces New Leadership Team
02/09/2025 12:46
CorMedix Inc CRMD.O: CORMEDIX COMPLETES ACQUISITION OF MELINTA THERAPEUTICS, RAISES FINANCIAL GUIDANCE AND ANNOUNCES NEW LEADERSHIP TEAM CORMEDIX INC - PRO FORMA 2025 REVENUES ESTIMATED AT $325-$350 MILLION Source text: ID:nGNXbjDwlv Further company coverage: CRMD.O
Recent news on CorMedix
See all newsBrief: Cormedix Announces FDA Acceptance For Priority Review Of Supplemental NDA For Rezzayo
U.S. STOCKS ON THE MOVE-Tapestry, Cisco, Sandisk
U.S. STOCKS ON THE MOVE-EnerSys, Netflix, Salesforce
U.S. STOCKS ON THE MOVE-Cerebras, Madison Square Garden Sports
CorMedix Inc. reports results for the quarter ended June 30 - Earnings Summary